Serum prolactin levels and their relationship to survival in women with operable breast cancer
- PMID: 7782804
- DOI: 10.1016/0895-4356(94)00201-z
Serum prolactin levels and their relationship to survival in women with operable breast cancer
Abstract
The prognostic value of serum prolactin levels was assessed in a sequential series of 739 patients who were initially treated at Guy's Hospital, London, between 1975 and 1980. Prolactin was measured in 472 patients 1 day before (Hpr1) and in 457 patients 10 days after (Hpr2) mastectomy. Follow-up of the patients was up to August 1992 giving 6139 women-years with a median follow-up time of 11.5 years (13.7 for patients still living and 5.1 for those dead). The association between the three prolactin variables and reproductive and clinical factors was examined before assessing the prognostic value of prolactin levels in terms of overall, disease-specific and disease-free survival. Multivariate survival models were used in order to adjust for the effect of other prognostic variables. These were found to be: tumour size, degree of nodal involvement, tumour grade and age at diagnosis. The results showed that high Hpr2 or high postoperative increase in prolactin (i.e. Hpr2-Hpr1) were significantly related to shorter disease-specific survival (p = 0.04 and 0.01, respectively) in postmenopausal women. In addition there was some indication, which did not attain formal significance, for this association to occur for disease-free survival. Thus the rise in blood prolactin levels after surgery may be a weak indicator of poor prognosis of breast cancer in postmenopausal women.
Similar articles
-
Serum prolactin levels in women with breast cancer and their relationship to survival.Eur J Cancer Clin Oncol. 1986 Apr;22(4):487-92. doi: 10.1016/0277-5379(86)90116-1. Eur J Cancer Clin Oncol. 1986. PMID: 3732352
-
Prediction of recurrence in operable breast cancer by postoperative changes in prolactin secretion.Oncology. 1995 Nov-Dec;52(6):439-42. doi: 10.1159/000227507. Oncology. 1995. PMID: 7478427
-
Reproductive history and prognosis in patients with operable breast cancer.Cancer. 1994 Sep 1;74(5):1591-4. doi: 10.1002/1097-0142(19940901)74:5<1591::aid-cncr2820740515>3.0.co;2-#. Cancer. 1994. PMID: 8062190
-
Relation between tumour size and plasma prolactin levels in premenopausal patients with breast carcinoma. A preliminary report.Acta Radiol Oncol. 1985 Jan-Feb;24(1):57-9. doi: 10.3109/02841868509134365. Acta Radiol Oncol. 1985. PMID: 2984903
-
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687650 Review.
Cited by
-
What Is Breast in the Bone?Int J Mol Sci. 2016 Oct 22;17(10):1764. doi: 10.3390/ijms17101764. Int J Mol Sci. 2016. PMID: 27782069 Free PMC article. Review.
-
Association of gene polymorphisms in prolactin and its receptor with breast cancer risk in Taiwanese women.Mol Biol Rep. 2011 Oct;38(7):4629-36. doi: 10.1007/s11033-010-0596-y. Epub 2010 Dec 2. Mol Biol Rep. 2011. PMID: 21125332
-
The role of prolactin in mammary carcinoma.Endocr Rev. 2003 Feb;24(1):1-27. doi: 10.1210/er.2001-0036. Endocr Rev. 2003. PMID: 12588805 Free PMC article. Review.
-
Prolactin and breast cancer etiology: an epidemiologic perspective.J Mammary Gland Biol Neoplasia. 2008 Mar;13(1):41-53. doi: 10.1007/s10911-008-9063-y. Epub 2008 Feb 2. J Mammary Gland Biol Neoplasia. 2008. PMID: 18246319 Review.
-
Post-diagnostic antipsychotic use and cancer mortality: a population based cohort study.BMC Cancer. 2020 Aug 24;20(1):804. doi: 10.1186/s12885-020-07320-3. BMC Cancer. 2020. PMID: 32831062 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical